Community post
US phage therapy company Adaptive Phage Therapeutics has received a $9.8-million Department of Defense Award to develop phage-based vaccine candidates against SARS-CoV-2.
Topics
Links
| Source | Capsid & Tail #89 |
|---|---|
| Original post | Original post |